These novel medications , Tirzepatide , represent a significant advancement in managing obesity and potentially associated ailments . These drugs are categorized as GLP-1 receptor agonists , meaning they https://janicegrhs779980.arwebo.com/63936653/semaglutide-a-thorough-examination-into-incretin-copyright